Financial Contrast: Taysha Gene Therapies (NASDAQ:TSHA) versus AIM ImmunoTech (NYSE:AIM)
Taysha Gene Therapies (NASDAQ:TSHA – Get Free Report) and AIM ImmunoTech (NYSE:AIM – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, analyst recommendations, profitability, institutional ownership and valuation. Valuation and Earnings This table compares […]
More Stories
Primoris Services Co. (NASDAQ:PRIM) Given Average Rating of “Buy” by Analysts
Primoris Services Co. (NASDAQ:PRIM – Get Free Report) has received a consensus rating of “Buy” from the six research firms...
Analysts Set Texas Instruments Incorporated (NASDAQ:TXN) PT at $210.05
Texas Instruments Incorporated (NASDAQ:TXN – Get Free Report) has been given an average recommendation of “Hold” by the twenty-three brokerages...
HealthEquity, Inc. (NASDAQ:HQY) Receives Average Recommendation of “Moderate Buy” from Analysts
HealthEquity, Inc. (NASDAQ:HQY – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the fourteen brokerages...
Prime Medicine, Inc. (NYSE:PRME) Receives $12.67 Average PT from Brokerages
Prime Medicine, Inc. (NYSE:PRME – Get Free Report) has been given a consensus recommendation of “Buy” by the eleven ratings...
Fund L.P. Forager Sells 597 Shares of Regional Management Corp. (NYSE:RM) Stock
Regional Management Corp. (NYSE:RM – Get Free Report) major shareholder Fund L.P. Forager sold 597 shares of the stock in...
Fund L.P. Forager Sells 597 Shares of Regional Management Corp. (NYSE:RM) Stock
Regional Management Corp. (NYSE:RM – Get Free Report) major shareholder Fund L.P. Forager sold 597 shares of the stock in...